Highlights Haemonetics Corporation

Equities

HAE

US4050241003

Real-time Estimate Cboe BZX Other stock markets 11:25:31 2024-06-10 am EDT			5-day change	1st Jan Change
85.92 ^USD	+0.36%		+1.06%	+0.46%

May. 29	Haemonetics Insider Sold Shares Worth $1,144,208, According to a Recent SEC Filing	MT
May. 29	Haemonetics Insider Sold Shares Worth $775,253, According to a Recent SEC Filing	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Haemonetics Prices Upsized Private Placement of $600 Million Convertible Senior Notes	May. 23	MT
Haemonetics Plans Notes Offering	May. 21	MT
Haemonetics Seeks Acquisitions	May. 09	CI
Haemonetics' Fiscal Q4 Adjusted Earnings, Revenue Rise	May. 09	MT
Haemonetics Corporation Reports Earnings Results for the Full Year Ended March 30, 2024	May. 09	CI
Haemonetics Corporation Reports Earnings Results for the Fourth Quarter Ended March 30, 2024	May. 09	CI
Haemonetics Corporation Provides Revenue Guidance for the Fiscal Year 2025	May. 09	CI
Haemonetics Corporation Receives FDA Clearance for New TEG®? 6s Global Hemostasis - HN Cartridge	Apr. 04	CI
Haemonetics Corporation completed the acquisition of Advanced Cooling Therapy, Inc.	Mar. 31	CI
Haemonetics to Acquire Attune Medical for $160 Million	Mar. 05	MT
Haemonetics Corporation entered into a definitive agreement to acquire Advanced Cooling Therapy, Inc. for approximately $160 million.	Mar. 04	CI
Haemonetics Q3 Adjusted Earnings, Revenue Increase; Shares Rise	Feb. 08	MT
Haemonetics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended December 30, 2023	Feb. 08	CI
Haemonetics Corporation Updates Revenue Guidance for the Fiscal Year 2024	Feb. 08	CI
Haemonetics Completes $255 Million Acquisition of OpSens	Dec. 12	MT
OpSens Brief: NYSE's Haemonetics Completed Acquisition	Dec. 12	MT
Haemonetics Corporation (NYSE : HAE) completed the acquisition of Opsens Inc. (TSX : OPS) for approximately CAD 330 million.	Dec. 11	CI
OpSens Receives Final Order For Its Acquisition By NYSE's Haemonetics	Dec. 08	MT
OpSens Brief: Says Received Final Order For Its Acquisition By NYSE's Haemonetics	Dec. 08	MT
Opsens Shareholders Approve Arrangement With Haemonetics	Dec. 01	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Haemonetics Corporation

Equities

HAE

US4050241003

Highlights

Filters